NovoCure Ltd financial data

Symbol
NVCR on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
No. 4 The Forum, Grenville Street, St. Helier, Jersey
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 340 % -51.6%
Quick Ratio 12.9 % -39.5%
Debt-to-equity 226 % +27%
Return On Equity -41.5 % +11.5%
Return On Assets -12.7 % +24.6%
Operating Margin -27.5 % +38.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 108M shares +1.25%
Common Stock, Shares, Outstanding 108M shares +1.27%
Entity Public Float 1.42B USD -50%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 108M shares +1.38%
Weighted Average Number of Shares Outstanding, Diluted 108M shares +1.38%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 578M USD +14.6%
Cost of Revenue 136M USD +9.36%
Research and Development Expense 213M USD -4.84%
Selling and Marketing Expense 231M USD +6.26%
General and Administrative Expense 157M USD -3.62%
Operating Income (Loss) -159M USD +29.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -114M USD +38.4%
Income Tax Expense (Benefit) 35.3M USD +207%
Net Income (Loss) Attributable to Parent -150M USD +24.1%
Earnings Per Share, Basic -1.4 USD/shares +24.7%
Earnings Per Share, Diluted -1.4 USD/shares +24.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 185M USD +19.7%
Accounts Receivable, after Allowance for Credit Loss, Current 67.1M USD +2.96%
Inventory, Net 39.1M USD +6.22%
Assets, Current 1.1B USD +4.51%
Property, Plant and Equipment, Net 73.3M USD +60.8%
Operating Lease, Right-of-Use Asset 28.3M USD -2.36%
Other Assets, Noncurrent 12.2M USD -1.55%
Assets 1.22B USD +6.6%
Employee-related Liabilities, Current 51M USD +25.2%
Contract with Customer, Liability, Current 14.9M USD
Liabilities, Current 735M USD +368%
Long-term Debt and Lease Obligation 0 USD -100%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 21.1M USD -4.13%
Other Liabilities, Noncurrent 18K USD -76%
Liabilities 861M USD +14.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.38M USD -170%
Retained Earnings (Accumulated Deficit) -1.09B USD -16%
Stockholders' Equity Attributable to Parent 361M USD -8.36%
Liabilities and Equity 1.22B USD +6.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -37.5M USD +40%
Net Cash Provided by (Used in) Financing Activities 89.5M USD +418%
Net Cash Provided by (Used in) Investing Activities -19.5M USD +53.9%
Common Stock, Shares, Issued 108M shares +1.27%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 32.7M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 189M USD +20.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.94M USD +12564%
Deferred Tax Assets, Valuation Allowance 375M USD +3.88%
Deferred Tax Assets, Gross 386M USD +4.19%
Operating Lease, Liability 35.6M USD +45.1%
Payments to Acquire Property, Plant, and Equipment 40.7M USD +52.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -153M USD +22.2%
Lessee, Operating Lease, Liability, to be Paid 42.3M USD +49%
Property, Plant and Equipment, Gross 79.4M USD +41.2%
Operating Lease, Liability, Current 8.22M USD +41.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.13M USD +54.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.75M USD +40.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.7M USD +74.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.56M USD +46.3%
Deferred Tax Assets, Operating Loss Carryforwards 99.7M USD +52.3%
Unrecognized Tax Benefits 18K USD -76.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.32M USD +30.1%
Additional Paid in Capital 1.45B USD +9.01%
Deferred Tax Assets, Net of Valuation Allowance 10.7M USD +16.6%
Share-based Payment Arrangement, Expense 115M USD -10.3%